Impact of IVDR on Clinical Diagnostics Practices

This guide outlines the implications of the European Union's In Vitro Diagnostics Regulation (IVDR) on clinical diagnostics, particularly focusing on the transition from the previous In Vitro Diagnostic Medical Devices Directive (IVDD). The IVDR introduces new pre- and post-market requirements that affect manufacturers, hospitals, and labs, necessitating compliance with updated standards for IVD devices. The document details how the IVDR mandates that all existing and new IVD devices meet these requirements, with a phased implementation timeline extending to 2028 for certain device classes. It highlights the challenges faced by laboratories, such as the need for revalidation of in-house assays and the requirement for technical documentation of software used in testing. The guide emphasizes the importance of collaboration between clinical laboratories and manufacturers to ensure access to compliant tests, while also addressing the resource implications of meeting the new regulatory demands. The document serves as a comprehensive resource for understanding the operational changes required under the IVDR.